Ratings Egyptian Chemical Industries

Equities

EGCH

EGS38201C017

End-of-day quote Egyptian Exchange Other stock markets 18:00:00 2024-04-29 EDT			5-day change	1st Jan Change
6.83 ^EGP	-3.39%		-15.68%	-49.59%

02-29	Egyptian Chemical Industries Reports Earnings Results for the Half Year Ended December 31, 2023	CI
01-29	Egyptian Chemical Industries announced that it expects to receive EGP 4 billion in funding	CI

Strengths

The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
The company returns high margins, thereby supporting business profitability.
The company's share price in relation to its net book value makes it look relatively cheap.
The company has a low valuation given the cash flows generated by its activity.
Over the last twelve months, the sales forecast has been frequently revised upwards.
The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

Weaknesses

The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.

Ratings chart - Surperformance

Sector: Diversified Chemicals

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
EGYPTIAN CHEMICAL INDUSTRIES	-49.59%	174M	-	-
SHIN-ETSU CHEMICAL CO., LTD.	+1.22%	76.93B		B
BASF SE	-0.28%	46.86B		A-
DUPONT DE NEMOURS, INC.	+1.07%	32.74B		C
PIDILITE INDUSTRIES LIMITED	+10.05%	18.58B		B
BRENNTAG SE	-9.81%	11.54B		B
EASTMAN CHEMICAL COMPANY	+6.79%	11.14B		A-
SYENSQO SA/NV	-6.33%	9.8B		-
ASAHI KASEI CORPORATION	+5.97%	9.72B		A-
SRF LIMITED	+8.06%	9.3B		C-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes